Does levosimendan act as a Ca 2+ sensitizer or PDE 3 inhibitor?: Commentary on Orstavik et al ., Br J Pharmacol 171: 5169–5181
Linked Article This article is a Commentary on Orstavik O, Ata SH, Riise J, Dahl CP, Andersen GO, Levy FO, Skomedal T, Osnes J‐B, and Qvigstad E (2014). PDE3‐inhibition by levosimendan is sufficient to account for its inotropic effect in failing human heart . Br J Pharmacol 171: 5169–5181. doi: 10.1...
Saved in:
Published in | British journal of pharmacology Vol. 172; no. 18; pp. 4594 - 4596 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
01.09.2015
|
Online Access | Get full text |
Cover
Loading…
Abstract | Linked Article
This article is a Commentary on Orstavik O, Ata SH, Riise J, Dahl CP, Andersen GO, Levy FO, Skomedal T, Osnes J‐B, and Qvigstad E (2014). PDE3‐inhibition by levosimendan is sufficient to account for its inotropic effect in failing human heart . Br J Pharmacol 171: 5169–5181. doi:
10.1111/bph.12647 |
---|---|
AbstractList | Linked Article
This article is a Commentary on Orstavik O, Ata SH, Riise J, Dahl CP, Andersen GO, Levy FO, Skomedal T, Osnes J‐B, and Qvigstad E (2014). PDE3‐inhibition by levosimendan is sufficient to account for its inotropic effect in failing human heart . Br J Pharmacol 171: 5169–5181. doi:
10.1111/bph.12647 |
Author | Endoh, Masao |
Author_xml | – sequence: 1 givenname: Masao surname: Endoh fullname: Endoh, Masao organization: Department of Pharmacology Yamagata University School of Medicine Yamagata Japan |
BookMark | eNotkD1PwzAYhC1UJNrCwD94VwQpdhzbSRcEaflSpXboHr1xHDWQxJUdVYKpYmPmH_aXED5uueF0p9MzIoPWtoaQc0YnrNd1vt1MWCij5IgMWaRkIHjMBmRIKVUBY3F8Qkbev1Dah0oMycfMGg-12VlfNaYtsAXUHaAHhBQhvARvWl911btxYB2sZnPgULWbKq86626mkNqmL3bo3sC2sHS-w131CqY77D-xhskV3Dl4htUGXYPa1sAUm4JgMjnsvwSL2Sk5LrH25uzfx2R9P1-nj8Fi-fCU3i4CraIkyLWSuZSSJrzkcYg5R6USVnAhaRnKwoQoolJjLjSKQhSolYmNoVHERGmiko_Jxd-sdtZ7Z8ps66qmv50xmv2wy3p22S87_g3_dGLG |
CitedBy_id | crossref_primary_10_1021_acs_biochem_6b00758 crossref_primary_10_1007_s00210_022_02333_0 crossref_primary_10_1093_ehjcvp_pvz065 crossref_primary_10_1007_s00210_022_02348_7 |
Cites_doi | 10.1253/circj.CJ-08-0838 10.1097/00005344-200209000-00001 10.1161/01.RES.83.2.230 10.1006/jmcc.1998.0677 10.1161/CIRCRESAHA.106.146670 10.1007/s00210-002-0627-x 10.1016/0022-2828(95)90009-8 10.1016/S0140-6736(11)61126-4 10.1111/bph.12647 10.1161/01.RES.73.6.981 10.1038/sj.bjp.0706292 |
ContentType | Journal Article |
DBID | AAYXX CITATION |
DOI | 10.1111/bph.12649 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1476-5381 |
EndPage | 4596 |
ExternalDocumentID | 10_1111_bph_12649 |
GroupedDBID | --- .3N .55 .GJ 05W 0R~ 1OC 23N 24P 2WC 31~ 33P 36B 3O- 3SF 3V. 4.4 52U 52V 53G 5GY 6J9 7RV 7X7 8-0 8-1 88E 8AO 8FE 8FH 8FI 8FJ 8R4 8R5 8UM A00 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAYXX AAZKR ABCUV ABDBF ABPVW ABQWH ABUWG ABXGK ACAHQ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFKRA AFPWT AFRAH AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB AOIJS ATUGU AZBYB AZVAB B0M BAFTC BAWUL BBNVY BENPR BFHJK BHBCM BHPHI BKEYQ BMXJE BPHCQ BRXPI BVXVI C45 CAG CCPQU CITATION COF CS3 DCZOG DIK DRFUL DRMAN DRSTM DU5 E3Z EAD EAP EAS EBC EBD EBS ECV EJD EMB EMK EMOBN ENC ESX EX3 F5P FUBAC FYUFA G-S GODZA GX1 H.X HCIFZ HGLYW HMCUK HYE HZ~ J5H KBYEO LATKE LEEKS LH4 LITHE LK8 LOXES LSO LUTES LW6 LYRES M1P M7P MEWTI MK0 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ N9A NAPCQ NF~ O66 O9- OIG OK1 OVD P2P P2W P4E PQQKQ PROAC PSQYO Q.N Q2X QB0 RIG ROL RPM RWI SJN SUPJJ SV3 TEORI TR2 TUS UKHRP UPT WBKPD WH7 WHWMO WIH WIJ WIK WIN WOHZO WOW WVDHM WXSBR X7M XV2 Y6R YHG ZGI ZXP ZZTAW ~8M ~S- |
ID | FETCH-LOGICAL-c749-bc76b666093f382ab3a7791d3560f26de2a54fcab5ca5d5dac7e8ee04415fe4f3 |
ISSN | 0007-1188 |
IngestDate | Fri Aug 23 01:30:32 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 18 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c749-bc76b666093f382ab3a7791d3560f26de2a54fcab5ca5d5dac7e8ee04415fe4f3 |
PageCount | 3 |
ParticipantIDs | crossref_primary_10_1111_bph_12649 |
PublicationCentury | 2000 |
PublicationDate | 2015-09-00 |
PublicationDateYYYYMMDD | 2015-09-01 |
PublicationDate_xml | – month: 09 year: 2015 text: 2015-09-00 |
PublicationDecade | 2010 |
PublicationTitle | British journal of pharmacology |
PublicationYear | 2015 |
References | e_1_2_4_3_1 e_1_2_4_5_1 e_1_2_4_4_1 e_1_2_4_7_1 e_1_2_4_6_1 e_1_2_4_9_1 Endoh M (e_1_2_4_8_1) 1986; 73 e_1_2_4_10_1 e_1_2_4_11_1 e_1_2_4_12_1 Blinks JR (e_1_2_4_2_1) 1986; 73 e_1_2_4_13_1 e_1_2_4_14_1 |
References_xml | – volume: 73 start-page: III85 year: 1986 ident: e_1_2_4_2_1 article-title: Modification of myofibrillar responsiveness to Ca++ as an inotropic mechanism publication-title: Circulation contributor: fullname: Blinks JR – ident: e_1_2_4_7_1 doi: 10.1253/circj.CJ-08-0838 – ident: e_1_2_4_6_1 doi: 10.1097/00005344-200209000-00001 – ident: e_1_2_4_5_1 doi: 10.1161/01.RES.83.2.230 – volume: 73 start-page: III117 year: 1986 ident: e_1_2_4_8_1 article-title: Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle publication-title: Circulation contributor: fullname: Endoh M – ident: e_1_2_4_11_1 doi: 10.1006/jmcc.1998.0677 – ident: e_1_2_4_4_1 doi: 10.1161/CIRCRESAHA.106.146670 – ident: e_1_2_4_13_1 doi: 10.1007/s00210-002-0627-x – ident: e_1_2_4_9_1 doi: 10.1016/0022-2828(95)90009-8 – ident: e_1_2_4_3_1 doi: 10.1016/S0140-6736(11)61126-4 – ident: e_1_2_4_10_1 doi: 10.1111/bph.12647 – ident: e_1_2_4_12_1 doi: 10.1161/01.RES.73.6.981 – ident: e_1_2_4_14_1 doi: 10.1038/sj.bjp.0706292 |
SSID | ssj0014775 |
Score | 2.1979923 |
Snippet | Linked Article
This article is a Commentary on Orstavik O, Ata SH, Riise J, Dahl CP, Andersen GO, Levy FO, Skomedal T, Osnes J‐B, and Qvigstad E (2014).... |
SourceID | crossref |
SourceType | Aggregation Database |
StartPage | 4594 |
Title | Does levosimendan act as a Ca 2+ sensitizer or PDE 3 inhibitor?: Commentary on Orstavik et al ., Br J Pharmacol 171: 5169–5181 |
Volume | 172 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaWcuGCeArKQyMEvXiz2thJnPSC6HarUgT0sEi9rezE1kagZLUJlag4VNw48w_7SxjnTUGocImSKI6TfF_GM56HCXkuktgYwQKnMlc9aX8pFvoON14ieKCFqeoWvH0XHH7wjk78k9Ho6zC7pFST-OyPeSX_gyqeQ1xtluw_INvdFE_gPuKLW0QYt1fCeD_XBf2kT_PC1uhP8Fe1GY-yoJLOJGUv2B4tbIB6mZ7pjY08P96fU07TbJWq1E7W8wM7I2CTRGwIufW2Z_S9zXU5TT9SXTaREGGEOE5qJtig_bbaNXWFa9tbJ1gbNMF9t14c5XLVpEGJinVfLrub0J9nSb6qk4cKmQ_nIly_C7bq5atw0GSpJaquRaonAgfFqvuLzBVsSK5wIEI9v171uBmO8TD4i6hX69XERaUu6sez1od_aZjrgg9bswebLqum18h1hmKqcvK_ftP5oDwh6vUvmndq6lLZOLCu14E2M1BLFrfIzcaegFc1OW6Tkc7ukJ0Goi9jWPT5dcUYduB48O3vkm-WQTBkECCDQBYgYSaBUej5A_kGkD_AoePPy13ouQN5Bi13QJcX59_xuSZj2NvAUd8tIGd2wTLm4vyH5co9sjiYL2aHTrMqhxMLL3JULAKFNu804oaHTCouhYjchKPqbFiQaCZ9z8RS-bH0Ez-RsdCh1lNrtxvtGX6fbGV5ph8QMMokUeRpVyq8szSSKW5QXeLGBJxP2UPyrP24y3Vde2X5G3jbV7noEbnR0_Ux2So3n_UTVCZL9bTC_Cdwr27n |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Does+levosimendan+act+as+a+Ca+2%2B+sensitizer+or+PDE+3+inhibitor%3F%3A+Commentary+on+Orstavik+et%E2%80%89al+.%2C+Br+J+Pharmacol+171%3A+5169%E2%80%935181&rft.jtitle=British+journal+of+pharmacology&rft.au=Endoh%2C+Masao&rft.date=2015-09-01&rft.issn=0007-1188&rft.eissn=1476-5381&rft.volume=172&rft.issue=18&rft.spage=4594&rft.epage=4596&rft_id=info:doi/10.1111%2Fbph.12649&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_bph_12649 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1188&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1188&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1188&client=summon |